Inovio Pharmaceuticals, Inc.
Reports in 17d· 2026-05-13
-24.2% · 90d
$1.16
+0.01 (+0.87%)
News
(1)April 2026
INOVIO PHARMACEUTICALS, INC. — DEF 14A Filing
INOINOVIO PHARMACEUTICALS, INC.
# 🧾 What This Document Is This is a **DEF 14A, or "Proxy Statement."** It’s a formal document a company sends to its shareholders ahead of an annual meeting. Its purpose is to give shareholders the information they need to vote on important company matters. Think of it as an invitation to the compa
Read summaryView on SEC EDGAR
Peers in Biotechnology
VRTX#1
Vertex Pharmaceuticals Incorporated
$113.64B+0.64%
REGN#2
Regeneron Pharmaceuticals, Inc.
$78.80B-0.99%
ARGX#3
argenx SE
$49.22B+1.97%
ALNY#4
Alnylam Pharmaceuticals, Inc.
$42.61B-1.82%
ONC#5
BeOne Medicines AG
$34.75B+0.39%
INSM#6
Insmed Incorporated
$34.45B-0.37%
RPRX#7
Royalty Pharma plc
$27.86B+0.84%
BNTX#8
BioNTech SE
$23.26B-0.11%
ROIV#9
Roivant Sciences Ltd.
$20.38B+1.10%
MRNA#10
Moderna, Inc.
$20.34B-1.57%